马上注册登录,享用更多感控资源,助你轻松入门。
您需要 登录 才可以下载或查看,没有账号?注册
|
×
本帖最后由 茶韵幽香 于 2015-12-7 13:23 编辑
2015年11月16日-22日,世界首个提高抗生素认识周里,
一、美国CDC网站公布:
More than 120 Partners Join CDC to Fight Antibiotic ResistanceThe President has proclaimed Nov. 16-22 “Get Smart About Antibiotics Week.” Get Smart Week builds on the momentum generated at the White House Forum on Antibiotic Stewardship, where more than 150 organizations pledged to improve antibiotic use and slow the spread of antibiotic resistance.
Antibiotic-Preserving Strategies Must Be Implemented to Battle Resistance ARLINGTON, VA (November 16, 2015) – Modern medicine is largely dependent on the efficacy of antibiotics and other antimicrobials. Yet, the ability to treat infections successfully with antibiotics is hampered by resistance due to their overuse and misuse. Well-documented and properly coordinated strategies like stewardship of antibiotics, expanded surveillance of antibiotic resistance, as well as investment in new drug development and diagnostic testing can work to reverse this alarming trend. The Society for Healthcare Epidemiology of America (SHEA) is pleased to join the Centers for Disease Control and Prevention (CDC) and other partners in [backcolor=rgba(255, 255, 255, 0.8)]"Get Smart about Antibiotics Week" to raise awareness of strategies and programs to address antibiotic resistance.
· Don’t continue antibiotics beyond 72 hours in hospitalized patients unless the patient has clear evidence of infection. · Avoid invasive devices (including central venous catheters, endotracheal tubes and urinary catheters) and, if required, use no longer than necessary. Device use poses a major risk for infections. · Dont perform urinalysis, urine culture, blood culture or C. difficile testing unless patients have signs or symptoms of infection. Tests can be falsely positive leading to over-diagnosis and overtreatment. · Don’t use antibiotics in patients with recent C. difficile without convincing evidence of need. Antibiotics pose a high risk of C. difficile recurrence. · Don’t continue surgical prophylactic antibiotics after the patient has left the operating room. ·
|